0% found this document useful (0 votes)
16 views65 pages

Pho Lecture 13-Std

Sexually transmitted infections (STIs) are significant public health concerns globally, with 340 million new cases annually, particularly affecting women and exacerbating HIV transmission. In Ethiopia, there is limited data on STIs, but a total of 451,686 cases were reported from 1988 to 2002, highlighting the need for better screening and treatment access. Effective management approaches include syndromic diagnosis and treatment, which can address multiple infections quickly, though they may risk over-treatment and miss asymptomatic cases.

Uploaded by

amir mohammed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
16 views65 pages

Pho Lecture 13-Std

Sexually transmitted infections (STIs) are significant public health concerns globally, with 340 million new cases annually, particularly affecting women and exacerbating HIV transmission. In Ethiopia, there is limited data on STIs, but a total of 451,686 cases were reported from 1988 to 2002, highlighting the need for better screening and treatment access. Effective management approaches include syndromic diagnosis and treatment, which can address multiple infections quickly, though they may risk over-treatment and miss asymptomatic cases.

Uploaded by

amir mohammed
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

1

Definition

 STIs are infectious diseases transmitted


by sexual activity & sometimes by blood
transfusion and from mother to child

2
Sexually transmitted
infections
Are important because of their
 Magnitude
 Potential complication (health social and
economic consequences)
 Interaction with HIV and AIDS
 Disproportionately involve women with
significant impact on reproductive potential

3
Epidemiology of STIs
 STIs are major public health problems globally
 Globally 340 million new cases of curable STIs occur
every year (69 million are in sub-Saharan Africa)
 In many developing countries STIs are among
the top five disease
 There is little information of STIs in Ethiopia
 Adult prevalence of HIV(2.2%) & syphilis (1.5%)
 Total of 451,686 cases reported between June 1988 &
June 2002 in Ethiopia

4
Distribution of STIs
 Prevalence higher in urban than rural
 Higher in unmarried & young adults
 More frequent among females than males
between the ages of 14-19
 After the age of 19, there is slight male
preponderance

5
STI statistics are
underestimated
Reasons for underestimation:
 People with asymptomatic STIs do not seek
treatment
 Poor access: health facilities offering treatment for
STIs may be too far away for many people
 Missed opportunity: people seeking other health care
such as antenatal services may not be routinely
screened for STIs
 Stigma: many patients perceive a stigma in attending
modern STIs services
 Non-reporting facilities: large number of people visit
private & traditional care providers that are not
reporting

6
Factors Affecting Transmission
 Behavioral Factors
 Socio-economic
-Many partner -Poverty
-Change of partners -Religious Restrictions
-Not using condoms - Women’s position
- Casual sex  Cultural
- Sex with CSW & partner
- Alcohol & substance use  Biological & clinical
- Assymptomatic STIs
 Personal factors - Age
- Delay in getting Rx - Sex
- Stigma being ashamed - Vulnerability, immunity
- Noncompliance to Rx

7
The link between STI &
HIV
 STIs facilitate the transmission of HIV

 The presence of HIV can make people more


susceptible to the acquisition of STIs

 The presence of HIV increases the


 severity of STIs and
 their resistance to standard treatment

8
Clinical presentations of HIV
and STI co-infection
 Atypical presentation of Syphilis rapid progression
to neurosyphilis
 Atypical lesions of chancroid
 Recurrent or persistent genital ulcers from HSV2
 Severe genital herpes may require suppression of
recurrence with acyclovir
 Human papilloma virus with exophytic genital warts
 Risk of treatment failure with single injection of
Benzathine Penicillin in primary syphilis
 Topical anti-fungals are less effective
9
Approaches to STI
diagnosis & Rx
 Classical approaches

 Etiologic diagnosis
 Clinical diagnosis
 Syndromic approach

10
Advantages of Syndromic Mx
 Sensitive & does not miss mixed infections
 Treats the patient at first visit
 Can be implemented at 10 health care level
 Uses flow charts with logical steps
 Simple, rapid & inexpensive
 Provides opportunity for education &
counseling

11
Limitations of syndromic Mx
 Risk of over treatment
 Asymptomatic infections are missed
 Requires prior research to determine the common
causes & Rx of a syndrome
 Needs training

12
SYNDROME COMMON CAUSE
Vaginal discharge Vaginitis (trichomoniasis, bacterial
vaginosis & Candida albicans)
Cervicitis (gonorrhea & Chlamydia)

Urethral discharge in men Gonorrhea & chlamydia

Genital ulcer Syphilis, chancroid & herpes

Lower abdominal pain Gonorrhea, chlamydia & mixed


anaerobes
Scrotal swelling Gonorrhea &chlamydia

Inguinal bubo LGV & Chancroid

Neonatal conjunctivitis Gonorrhea & Chlamydia

13
Steps in syndromic STI
management / Comprehensive
approach
 Syndromic diagnosis and treatment,
 History taking and examination
 Use of flow charts
 Education on risk reduction
 Providers initiated HIV Counseling & testing/ PIHCT
 Condom promotion and provision for safer sex
 Partners notification and management
 Follow up
 Referral

14
URETHRAL DISCHARGE

 Burning sensation on
urination Sexually Transmitted Infections
 Urethral discharge Urethral discharge
 Causes
 [Link]
 [Link]
 [Link]( some times)

15
Recommended treatment for
urethral discharge
Ciprofloxacin 500 mg tablet po stat
Or
Spectinomycin 2 grams IM stat

PLUS

Doxycycline 100 mg po bid for 7 days


Or
Tetracycline 500 mg po qid for 7 days
Or
Erythromycin 500mg po qid for 7 days

16
GENITAL ULCER

17
Causes of genital ulcer
Vesicular
HSV2: Genital Herpes
Non-Vesicualr
T. Pallidum: Syphilis
H. Ducreyi: Chancroid
C. Trachomatis: L1-L3: LGV
[Link]: Granuloma ingunale

18
Syphilis
 Primary Tertiary
 Solitary non tender hard ulcer/ - Cardiovascular: aortitis
Chancre - Neuro-syphilis
 Painless inguinal adenopathy
 Secondary
- Skin rash
- Alopecia
- Mucosal ulcerations
- Condylomata lata
- Generalized lymphadenopathy

19
Syphilis

Chancre Rash

20
Chancroid
 Painful Ulcer with soft
margins described as soft
chancre
 Inguinal adenopathy that
becomes necrotic and
fluctuant (buboes)
 High rates of HIV infection
among patients

Soft ulcer

21
Lymphogranuloma Venereum
(LGV)
 Caused by C. trachomatis serovars L1, L2, or L3.

 Clinical manifestation
 Tender inguinal & femoral lymphadenopathy

22
LGV

23
Granuloma inguinale
 Chronically progressive ulcerative disease
 Etiologic agent is Calymmatobacterium
granulomatis

24
GI

25
Genital herpes
 Multiple painful
vesicular genital
ulcers

26
Genital ulcer
Take Hx, & examine patient
Educate on risk reduction
No Offer HCT
Is ulcer vesicular, No Solitary Promote & provide
Recurrent or Non recurrent condoms
More than three ?
Non vesicular ?
Yes
yes
Treat HSV2

Educate on risk reduction


Offer HCT Treat for syphilis Chancroid
Promote & provide condoms
Partner managment And HSV2
Ask patient to return in 7d

No
Ulcer Refer
Ulcer healed?
No Improvin
Yes g yes
Educate on risk reduction Continue Rx for 10
Offer HCT days 27
Promote & provide
Recommended treatment for
genitalpenicillin
Benzathine ulcer 2.4 million units IM stat
Or
Doxycycline 100 mg bid for 14 days
Plus
Ciprofloxacin 500mg bid orally for 3 days
Or
Erythromycin tablets 500 mg qid for 7 days
Plus
Acyclovir 400mg tid orally for 10 days (200mg five
times per day of 10 day)

28
VAGINAL DISCHARGE

29
Causes of vaginal discharge
 Sexually transmitted
 Neisseria gonorrhoeae

 Chlamydia trachomatis

 Trichomonas vaginalis

 Endogenous infection
 Gardnerella vaginalis/ Bacterial vaginosis

 Candida albicans

 Others
 Foreign body
 Neoplasia

30
Causes (Cont)
 Gardnerella vaginalis/ Bacterial
vaginosis
 Homogeneous, thin, grayish-white discharge
that smoothly coats the vaginal walls
 Vaginal pH > 4.5
 Positive whiff-amine test
 Fishy odor when 10%KOH is added to a sample of
vaginal discharge
 “Clue cells” on saline wet mount

31
Clue cells

32
Causes (Cont)
 Candida albicans
 Risk factors: immunosuppression, increased
estrogen, diabetes, antibiotics
 C/F:
 white curd-like/"cottage cheese-like” discharge
 Itching / vulvar pruritus
 Erythema of vulva
 Lab:
 Wet mount with 10% KOH
 Yeast/ hyphae
 Culture –

33
Hypha
e

34
Causes (Cont)
 Trichomonas vaginalis
 Purulent , malodorous, green-yellow frothy discharge
 Burning, pruritus, dysuria & dyspareunia.
 Erythema of the vulva and vaginal mucosa
 Punctate hemorrhages on the vagina and cervix ("strawberry
cervix“)
 Motile Trichomonads on wet mount

35
Strawberry cervix Trichomonads

36
Causes (Cont)
 Neisseria gonorrhoeae
 vaginal pruritis & mucopurulent discharge
 Discharge from the cervix
 G-negative intracellular diplococci on G-stain
 Culture: Thayer Martin medium
 Chlamydia trachomatis
 Mucopurulent cervical discharge
 Investigations: PCR and Cell culture- expensive

37
Evaluation of patients with vaginal
discharge
 Risk assessment: Risk factors for cervicitis
 Age less than 25 years
 Having multiple sexual partner in the last three
months
 Having new partner in the last three months
 Having ever traded for sex
 Speculum examination to determine site of
infection

38
Vaginitis Vs Cervicitis
VAGINITIS CERVICITIS
Trichomoniasis, candidiasis, Gonorrhea & chlamydia
bacterial vaginosis
Most common cause of vaginal Less common cause of
discharge vaginal discharge
Less complications Major complications
Partner treatment unnecessary Partner treatment needed
Complication: PID, Premature rupture of membrane
Preterm labor, Infertility & Chronic pelvic pain

39
Vaginal discharge or vulval/Itching /Burning
Take Hx, examine patient (external,
speculum & bimanual) & assess risk
Educate on risk reduction
Abnormal discharge No
Offer HCT
present?
Promote & provide condoms
Yes
Yes
Lower abdominal tenderness /
Use LAP flowchart
cervical motion tenderness
No
Treat GC, CT, BV, TV
Yes
Is Risk assessment +?
No Treat for
Vulvar oedema/curd like Yes
Discharge, Erythema, Excoriations Candida A
Treat for BV present?
No
Educate, Offer HCT
40
Promote & provide condoms
Recommended treatment for
vaginal discharge
RISK ASSESMENT RISK ASSESMENT
POSITIVE NEGATIVE
Ciprofloxacin 500 mg po stat Metronidazole 500 mg bid for 7
or days
Spectinomycin 2 gm IM stat Plus
or Clotrimazole vaginal tabs 200
Ceftriaxone 125mg IM stat mg at bed time for 3 days
Plus
Doxycycline 100 mg po bid for 7 d
Plus
Metronidazole 500 mg bid for 7 d

41
Recommended treatment…
 During pregnancy
 Metronidazole, 250 mg orally, tid for 7 days
after 1st trimester or
 Metronidazole 2g orally as a single dose

42
LOWER ABDOMINAL
PAIN

43
Indications for hospitalizations
 Uncertain diagnosis
 Acute abdomen can not be excluded
 Pelvic or tuboovarian abscess is suspected
 Severe illness precludes management on an
outpatient basis
 Pregnancy
 The patient is unable to follow or tolerate an
outpatient regimen
 The patient has failed to respond to outpatient R x

44
45
Recommended treatment for
PIDOut patient In patent
Ciprofloxacin tablet 500 mg po Ceftriaxone 250 mg IV/IM daily
stat or
Ceftriaxone 250mg IM stat or Or
Spectinomycin 2 gm im bid
Spectinomycin 2 gm im stat Plus
Plus Doxycycline 100 mg bid for 14 days
Doxycycline tablet 100 mg po bid
for 14 days Plus
Plus Metronidazole 500 mg bid for 14 days
Metronidazole 500 mg bid for 14d or
Admit if there is no improvement Chloramphenicol 500 mg IV qid.
within 72 hours

46
INGUINAL BUBO
 Painful, often fluctuant, swelling of the lymph
nodes in the inguinal region (groin)
 Pathogens
 C. trachomatis (serovar L1, L2, and L3)

 H. ducreyi

 C. granulomatis

 T. pallidum( some times)


 Treat Chancroid, LGV & GI

47
Recommended treatment for
inguinal bubo
Ciprofloxacin 500 mg bid orally for 3 days
Or
Erythromycin 500 mg po qid for 7 days
Plus
Doxycycline 100mg bid orally for 14 days

*If fluctuant aspirate through healthy skin

48
Scrotal Swelling

49
Scrotal swelling
Painful testis/ epididymis

 < 25 years N. Gonorrhoea & [Link]


 > 25 years other organisms, TB possible
(Other infectious causes are brucellosis, mumps,
onchocerciasis or W. babcrofti)
 In pre-pubertal children is coliform,
pseudomonas or mumps virus
 Mumps epidedimorchitis is usually noted within a
week of parotid enlargement
 Other causes of scrotal swelling
 testicular torsion; Trauma; Tumor

 incarcerated inguinal hernia

50
Scrotal swelling

Take Hx, examine patient

no
Scrotal swelling No Reasure educate
Pain cnfirmed ? Analgesics Offer HCT
Promote & provide condoms
Yes
treat for GC/CT
Testis No Educate on risk reduction
rotated Offer HCT
Elevated Promote & provide condoms
paertener
Hx trauma
yes

Refer for
Surgical opinion

51
Recommended treatment
for scrotal swelling
Ciprofloxacin 500 mg po stat
Or
Spectinomycin 2 gm im stat
Plus
Doxycycline 100 mg PO bid for 7 days
Or
Tetracycline 500 mg PO bid for 7 days.

52
Neonatal Conjunctivitis

53
Neonatal Conjuctivitis
 It is a purulent conjuctivitis occurring in
a baby less than one month of age.
 Sight-threatening condition

 Common presentation are Redness, swelling of


the eye lid & discharge from the eye (sticky
eye)
 The most important causes are gonorrhoea (20-
75%) & chlamydia (15-35%)
 If caused by gonorrhoea, blindness often

follows

 For babies older than one month, the cause is


unlikely to be an STI
54
Eye discharge

Take Hx, examine patient

Bilateral unilateral No Reassure mother


swollen eye ? advice to return
If necessary
Yes
Treat for
GC/CT
Treat mother partner (s)
Educate on risk reduction
Offer HCT
Promote & provide condoms
revist

Improved
yes

no refer
Continue RX till completed
55
Management
 Prevention
 As soon as the baby is born, carefully wipe both
eyes with dry, clean cotton wool;

 Then apply 1% silver nitrate solution or 1%


tetracycline eye ointment into the infant’s eyes;
other options: 0.5% Erythromycin ointment or
2.5% povidone iodine solution;
 Treatment
 Ceftriaxon 125mg IM stat (max 50mg/kg) or
 Spectinomycin 25mg/kg IM stat (max 75mg) plus
 Erythromycin 50 mg/kg PO in four divided doses
for 14 days
56
PARTNER
MANAGEMENT

57
Advantages of Partner
Notification
 Break cycle of infection
 Eliminate asymptomatic infection

 Prevent re-infection

 Prevent complication by early

detection
 Education & risk reduction

counseling

58
Two Approaches to Partner
Management

[Link] referral (passive contact


tracing)
[Link] referral (active contact
tracing)

59
Patient referral could be done in
several ways
 By directly explaining about the STI &
the need for treatment
 Asking the partner to attend a health

center with out specifying the purpose


of the visit
 By giving a partner a card to attend

the center

60
Provider Referral
 Possible if index patients are prepared to
disclose full contact information
 It is resource intensive
 The success depends on health care
providers communication skills
 Can be used when
 Patients refuse to refer partner
 Patient has agreed to refer partners but they have
not come for treatment

61
Partner management
INDEX PATIENT TREATMENT OF PARTNER

Urethral discharge Treat for gonorrhea & Chlamydia


Vaginitis & Cervicitis Treat for gonorrhea & Chlamydia
Vaginitis No partner treatment needed
PID Treat for gonorrhea & Chlamydia
Scrotal swelling Treat for gonorrhea & Chlamydia
Inguinal bubo Treat for LGV
Neonatal conjunctivitis Treat for gonorrhea & Chlamydia
Genital ulcer Treat for syphilis & chancroid

62
GYNECOLOGIC
MANIFESTATIONS OF
HIV/AIDS
 For many women, gynecologic complaints are the
initial manifestation of HIV/AIDS.
 These conditions, which also exist in uninfected
women, can occur with higher frequency and
severity in women with HIV.
 Candida vaginitis and bacterial vaginosis
 Abnormal cervical cytology
 Vulvar and perianal pathology
 Pelvic inflammatory disease
 Genital ulcer disease (eg, HSV, chancroid, syphilis,
idiopathic)
 Menstrual disorders and ammenorrhea
PRIMARY CARE OF HIV
INFECTED WOMEN
 HIV therapy
 Health maintenance
 Medical care must include routine medical
screening (mammograms, breast self-
examination, nutritional counseling for
osteoporosis, smoking cessation, etc) and a
recognition that not all complaints are
necessarily HIV-related.
CHOICE OF CONTRACEPTION
FOR A WOMAN WITH HIV
 Specific contraceptives and their efficacy in
preventing pregnancy
 Prevention of transmission of HIV and other
sexually transmitted diseases
 Drug interactions between certain
antiretroviral agents and hormonal
contraceptives

You might also like